Archive for the 'Oncology' Category
March 24th, 2011 by admin
As workers battle against the radiation leakage from the now battered nuclear plant in northeastern Japan, civilians have fled the city of Tokyo including foreigners. People all over the world are drawing their attention towards public health officials out of fear. Health officials are turning towards potassium iodide pills to safeguard them from radiation, eluding the risks this medicine carries in the absence of a live nuclear threat.
Continue reading ‘Radiation from Fukushima Plant – High or Insignificant?’
March 9th, 2011 by admin
New research from the Virginia Bioinformatics Institute (VBI) has proven that there are very specific changes in the genetic makeup of people suffering from cancer and those who don’t have cancer. The researchers from VBI have developed a new technology that catches these genetic changes, which help in differentiating cancer patients from healthy individuals. The future purpose of this technology could be in creating a cancer predisposition test. The team also included scientists from the University of Texas Southwestern Medical Center.
Continue reading ‘Genetic Differences between Cancer and Non-Cancer Patients’
February 28th, 2011 by admin
MedTrust Online and Avantra Biosciences have entered into a partnership to involve clinicians in the earliest stages of molecular diagnostic assay development for Avantra Biosciences’ revolutionary QPDx multiplex immunoassay system.
Continue reading ‘MedTrust, Avantra Partner to Develop Biomarker Assays for Cancer’
January 27th, 2011 by admin
There are many reasons cancer patients can dread chemotherapy. It might kill their cancer, but those who go through it often wonder if the cure is just as bad as the disease. Among the uncomfortable symptoms is chemotherapy-induced vomiting. Ahmedabad, India-based Lincoln Pharmaceuticals has been granted a patent for its nasal drug delivery system (NDDS) of ondansetron hydrochloride, which prevents or arrests vomiting.
Continue reading ‘Nasal Delivery of Anti-vomiting Drug Patent Won’
January 26th, 2011 by admin
Eight months after Merck jumped into the driver’s seat to take control of Ariad’s late-stage cancer program ridaforolimus, the biotech is reporting that one of its Phase III study turned in statistically significant results. And the news quickly spurred a 36 percent increase in the biotech’s share price.
Continue reading ‘Ariad Shares Soar after Cancer Drug Clears Late-stage Trial’
November 29th, 2010 by admin
A $145-million U.S. Federal Government effort to harness the power of nanotechnology to improve the diagnosis, treatment, and prevention of cancer is producing innovations that will radically improve care for the disease. That’s the conclusion of an update on the status of the program, called the National Cancer Institute Alliance for Nanotechnology in Cancer. It appears in a monthly journal published by the American Chemical Society.
Continue reading ‘Nanotechnology Promises Big Benefits for Cancer Patients’
November 5th, 2010 by admin
Cancer Research UK is set to begin a Phase I trial for glioblastoma, a deadly form of brain cancer. Forty-five patients have been recruited to receive the vaccine IMA950. The drug contains 11 peptides that are found in tumors but not healthy tissue. They “train” T cells in the immune system to recognize cancer cells as unhealthy cells–and then to target and destroy them. No other brain cancer vaccines in development work the same way. Cancer Research notes that using multiple peptides increases the chances of eliciting an immune response.
Continue reading ‘Charity Funds Brain Cancer Vaccine Trial’
October 20th, 2010 by admin
Stomach cancer patients with a high expression of the molecule microRNA 451 show greater survival rates. This molecule could be a biomarker for treatment response. “The high presence of microRNA 451 enhances the response to treatment with chemo-radiotherapy and increases the survival of patients with stomach cancer,” explained Dr. Jesús García-Foncillas, chief researcher of the Pharmacogenomics Laboratory at the Applied Medical Research Centre (CIMA) and Director of Oncology at the University Hospital of Navarra. This was one of the results presented at the IV Congress of the Spanish Society for Pharmacogenetics and Pharmacogenomic, recently held at CIMA.
Continue reading ‘Molecule Increases Survival of Stomach Cancer Patients’
October 11th, 2010 by admin
After a major review of scientific information, six leading tobacco research and policy experts have concluded that a nicotine reduction strategy should be an urgent research priority because of its potential to profoundly reduce the death and disease from tobacco use. Their findings were published in the journal Tobacco Control.
Continue reading ‘Experts Urge Making Cigarettes Non-Addictive a Research Priority’
September 20th, 2010 by admin
Doctors once suggested her parents take her home to die, but a young Auckland girl’s winning determination to fight off cancer – and the unique treatment that helped – is now being used to save other lives. In 2007, Frances Everall, just four years of age, was not expected to survive an aggressive stage four neuroblastoma – a cancer of the nervous system – which was attacking her.
Continue reading ‘Frances Wouldn’t Be Alive Without Cord Blood’
